Lipotype GmbH has announced the launch of U.S. subsidiary, Lipotype Inc. With about 40% of Lipotype’s customers based in the U.S., the expansion will allow Lipotype’s team to provide local support.
Related: Unilever Ventures Invests $2M in Straand Prebiotic Scalp Care
Lipotype provides lipidomics analysis services to pharmaceutical, medical, cosmetic, food industry companies and academic customers from universities and research institutions. This team helps R&D facilities and labs to understand the complexity of lipid metabolism without committing to significant investments in instruments and specialist training, per Lipotype.
Lipotype’s mass spectrometry-based platform can be applied to analysis of biological samples and covers the analysis of more than 4200 lipids.
Oliver Uecke, Ph.D., CEO of Lipotype Inc., commented: “Thanks to all the trust and support our customers have been giving us, we have been able to better understand our customers’ needs and their projects. And the establishment of a U.S. subsidiary is a commitment from our side promising to serve them better.”
John Bajor, Unilever, commented: “Lipotype provides us with consistent and reliable service in the area of lipidomic sample analysis. Therefore, Lipotype establishing a U.S. subsidiary, geographically near our labs will certainly help us continue such endeavours."
